IL151922A0 - Transdermal therapeutic system for the delivery of lerisetron - Google Patents

Transdermal therapeutic system for the delivery of lerisetron

Info

Publication number
IL151922A0
IL151922A0 IL15192201A IL15192201A IL151922A0 IL 151922 A0 IL151922 A0 IL 151922A0 IL 15192201 A IL15192201 A IL 15192201A IL 15192201 A IL15192201 A IL 15192201A IL 151922 A0 IL151922 A0 IL 151922A0
Authority
IL
Israel
Prior art keywords
lerisetron
delivery
therapeutic system
transdermal therapeutic
transdermal
Prior art date
Application number
IL15192201A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL151922A0 publication Critical patent/IL151922A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15192201A 2000-03-30 2001-03-17 Transdermal therapeutic system for the delivery of lerisetron IL151922A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10015783A DE10015783C2 (de) 2000-03-30 2000-03-30 Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung
PCT/EP2001/003089 WO2001074338A1 (de) 2000-03-30 2001-03-17 Transdermales therapeutisches system zur abgabe von lerisetron

Publications (1)

Publication Number Publication Date
IL151922A0 true IL151922A0 (en) 2003-04-10

Family

ID=7636948

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15192201A IL151922A0 (en) 2000-03-30 2001-03-17 Transdermal therapeutic system for the delivery of lerisetron
IL151922A IL151922A (en) 2000-03-30 2002-09-25 Skin healing system to give restron

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151922A IL151922A (en) 2000-03-30 2002-09-25 Skin healing system to give restron

Country Status (16)

Country Link
US (1) US20040001881A1 (es)
EP (1) EP1267846B1 (es)
JP (1) JP2003528912A (es)
KR (1) KR100624500B1 (es)
AR (1) AR028525A1 (es)
AT (1) ATE310510T1 (es)
AU (1) AU782487B2 (es)
BR (1) BR0109893A (es)
CA (1) CA2403949C (es)
DE (2) DE10015783C2 (es)
ES (1) ES2254425T3 (es)
HU (1) HUP0204448A3 (es)
IL (2) IL151922A0 (es)
MX (1) MXPA02009103A (es)
NZ (1) NZ521099A (es)
WO (1) WO2001074338A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
WO2003100091A1 (en) * 2002-05-24 2003-12-04 Epidauros Biotechnologie Ag Means and methods for improved treatment using 'setrones'
GB0302662D0 (en) 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
WO2006028863A1 (en) * 2004-09-01 2006-03-16 Nexmed Holdings, Inc. Transdermal antiemesis delivery system, method and composition therefor
DE102004044578A1 (de) * 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
PL2450041T3 (pl) 2005-10-12 2019-02-28 Unimed Pharmaceuticals, Llc Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu
CN101909651B (zh) * 2007-11-22 2013-11-06 美德阿利克斯株式会社 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
FR2943253B1 (fr) * 2009-03-20 2011-04-22 Oreal Composition contenant l'association de madecassoside, d'une arginine et de polysorbate
JP5681883B2 (ja) * 2009-03-27 2015-03-11 株式会社 メドレックス 核酸を有効成分とする外用剤組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
US5256665A (en) * 1991-05-10 1993-10-26 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. Process for preparing new 2-piperazinylbenzimidazole
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JPH10167956A (ja) * 1996-12-11 1998-06-23 Hisamitsu Pharmaceut Co Inc セロトニン受容体拮抗薬含有経皮投与製剤
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US6136807A (en) * 1998-11-10 2000-10-24 3M Innovative Properties Company Composition for the transdermal delivery of lerisetron

Also Published As

Publication number Publication date
AU6210701A (en) 2001-10-15
US20040001881A1 (en) 2004-01-01
HUP0204448A2 (en) 2003-05-28
EP1267846A1 (de) 2003-01-02
DE50108168D1 (de) 2005-12-29
ES2254425T3 (es) 2006-06-16
JP2003528912A (ja) 2003-09-30
AU782487B2 (en) 2005-08-04
HUP0204448A3 (en) 2004-07-28
CA2403949C (en) 2008-09-16
NZ521099A (en) 2006-11-30
ATE310510T1 (de) 2005-12-15
DE10015783A1 (de) 2001-10-11
KR100624500B1 (ko) 2006-09-18
BR0109893A (pt) 2003-04-01
KR20020084161A (ko) 2002-11-04
CA2403949A1 (en) 2002-09-26
IL151922A (en) 2007-10-31
WO2001074338A1 (de) 2001-10-11
EP1267846B1 (de) 2005-11-23
MXPA02009103A (es) 2004-08-12
AR028525A1 (es) 2003-05-14
DE10015783C2 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
IL148719A0 (en) Kinase inhibitors as therapeutic agents
AU1531502A (en) Composition for the transdermal delivery of fentanyl
AU2002221239A1 (en) Therapeutic benzimidazole compounds
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2001272535A1 (en) Transdermal therapeutic system for highly dispersed silicon dioxide
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
HK1075619A1 (en) New uses for anti-malarial therapeutic agents
AU2002210463A1 (en) Transdermal therapeutic system
AU2002210462A1 (en) Transdermal therapeutic system for treating restless-legs-syndrome
EP1450876A4 (en) INTEGRATED TRANSDERMAL DRUG DELIVERY SYSTEM
IL157692A0 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
AU2002308289A1 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
IL151922A0 (en) Transdermal therapeutic system for the delivery of lerisetron
HUP0200189A3 (en) Transdermal therapeutic system with nicotine
AU7662400A (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
IL137559A0 (en) Transdermal drug delivery system
AU2001243515A1 (en) Combination drug therapy
HUP0202592A3 (en) Transdermal delivery of lasofoxifene
AU5836700A (en) Peptides for therapeutic use
HU0001891D0 (en) Medicament for the treatment of migraine
IL152646A0 (en) Dosage of transdermal delivery systems
GB9911238D0 (en) Therapeutic use
AU2003297107A8 (en) Sacromastigophoric therapeutic agent delivery system
IL150334A0 (en) Transdermal drug delivery system
SI1268481T1 (sl) Inhibitorji kinaze kot zdravila

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed